Back to Journals » Neuropsychiatric Disease and Treatment » Volume 5 » default

Neuropsychiatric Disease and Treatment


Archive: Volume 5, 2009

Clinical features of adolescents with deliberate self-harm: A case control study in Lisbon, Portugal

Diogo F Guerreiro, Ema L Neves, Rita Navarro, et al

Neuropsychiatric Disease and Treatment 2009, 5:611-617

Published Date: 12 November 2009

Coenzyme Q10 effects in neurodegenerative disease

Meredith Spindler, M Flint Beal, Claire Henchcliffe

Neuropsychiatric Disease and Treatment 2009, 5:597-610

Published Date: 9 November 2009

Current and emerging treatments for amyotrophic lateral sclerosis

Stefano Zoccolella, Andrea Santamato, Paolo Lamberti

Neuropsychiatric Disease and Treatment 2009, 5:577-595

Published Date: 3 November 2009

Psychological and behavioral disease during developmental age: the importance of the alliance with parents

Michela Gatta, Elisabetta Ramaglioni, Jessica Lai, et al.

Neuropsychiatric Disease and Treatment 2009, 5:541-546

Published Date: 22 October 2009

Sleep disorders in Parkinson’s disease

Israt Jahan, Robert A Hauser, Kelly L Sullivan, Amber Miller, et al.

Neuropsychiatric Disease and Treatment 2009, 5:535-540

Published Date: 15 October 2009

Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy

Ghaydaa A Shehata, Abd El-aziz M Bateh, Sherifa A Hamed, et al

Neuropsychiatric Disease and Treatment 2009, 5:527-533

Published Date: 15 October 2009

Late- versus early-onset geriatric depression in a memory research center

Carol Dillon, Ricardo F Allegri, Cecilia M Serrano, et al

Neuropsychiatric Disease and Treatment 2009, 5:517-526

Published Date: 9 October 2009

Treatment of refractory complex partial seizures: role of vigabatrin

Elizabeth J Waterhouse, Kimberly N Mims, Soundarya N Gowda

Neuropsychiatric Disease and Treatment 2009, 5:505-515

Published Date: 6 October 2009

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia

Xinhua S Ren, Lawrence Herz, Shirley Qian, et al

Neuropsychiatric Disease and Treatment 2009, 5:491-498

Published Date: 30 September 2009

Body dysmorphic disorder: A complex and polymorphic affection

Patrizia Fiori, Luigi Maria Giannetti

Neuropsychiatric Disease and Treatment 2009, 5:477-481

Published Date: 9 September 2009

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

Jan K Buitelaar, J Antoni Ramos-Quiroga, Miguel Casas, et al

Neuropsychiatric Disease and Treatment 2009, 5:457-466

Published Date: 24 August 2009

Computerized assessment of pain drawing area: A pilot study

Anna Wenngren, Britt-Marie Stålnacke

Neuropsychiatric Disease and Treatment 2009, 5:451-456

Published Date: 20 August 2009

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder

Alla Avedisova, Vladimir Borodin, Ksenia Zakharova, et al

Neuropsychiatric Disease and Treatment 2009, 5:415-420

Published Date: 31 July 2009

Pregabalin in the management of partial epilepsy

Amir M Arain

Neuropsychiatric Disease and Treatment 2009, 5:407-413

Published Date: 31 July 2009

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset

Bernardo Dell’Osso, Massimiliano Buoli, Riccardo Riundi, Nazario D’Urso, et al.

Neuropsychiatric Disease and Treatment 2009, 5:399-404

Published Date: 14 July 2009

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression

Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida

Neuropsychiatric Disease and Treatment 2009, 5:393-398

Published Date: 14 July 2009

Treatment of obese patients with binge eating disorder using topiramate: a review

Paolo Leombruni, Luca Lavagnino, Secondo Fassino

Neuropsychiatric Disease and Treatment 2009, 5:385-392

Published Date: 7 July 2009

Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder

D Marazziti, S Baroni, L Palego, I Masala, G Consoli, M Catena Dell’Osso, G Giannaccini, A Lucacchini

Neuropsychiatric Disease and Treatment 2009, 5:363-367

Published Date: 1 July 2009

Imitation and communication skills development in children with pervasive developmental disorders

Andrea De Giacomo, Claudia Portoghese, Domenico Martinelli, Isabella Fanizza, et al.

Neuropsychiatric Disease and Treatment 2009, 5:355-362

Published Date: 18 June 2009

Review of teriflunomide and its potential in the treatment of multiple sclerosis

Clemens Warnke, Gerd Meyer zu Hörste, Hans-Peter Hartung, Olaf Stüve, et al.

Neuropsychiatric Disease and Treatment 2009, 5:333-340

Published Date: 27 May 2009

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Paul Shotbolt, Michael Samuel, Chris Fox, Anthony S David

Neuropsychiatric Disease and Treatment 2009, 5:327-332

Published Date: 25 May 2009

Frontal brain dysfunction in alcoholism with and without antisocial personality disorder

Marlene Oscar-Berman, Mary M Valmas, Kayle s Sawyer, Shalene M Kirkley, et al.

Neuropsychiatric Disease and Treatment 2009, 5:309-326

Published Date: 25 May 2009

Management of obsessive-compulsive disorder with fluvoxamine extended release

Lídia Ordacgi, Mauro V Mendlowicz, Leonardo F Fontenelle

Neuropsychiatric Disease and Treatment 2009, 5:301-308

Published Date: 26 May 2009

Current trends in the treatment of infantile spasms

Chang-Yong Tsao

Neuropsychiatric Disease and Treatment 2009, 5:289-299

Published Date: 19 May 2009

Update on the use of memantine in Alzheimer’s disease

Robert J van Marum

Neuropsychiatric Disease and Treatment 2009, 5:237-247

Published Date: 12 March 2009

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review

Paul Hammerness, Katherine McCarthy, Elizabeth Mancuso, Cassandra Gendron, Daniel Geller

Neuropsychiatric Disease and Treatment 2009, 5:215-226

Published Date: 25 March 2009

SAFA: A new measure to evaluate psychiatric symptoms detected in a sample of children and adolescents affected by eating disorders. Correlations with risk factors

Emilo Franzoni, Morena Monti, Alessandro Pellicciari, Carlo Muratore, Alberto Verrotti, et al

Neuropsychiatric Disease and Treatment 2009, 5:207-214

Published Date: 19 March 2009

Electroencephalographic and behavioral convulsant effects of hydrobromide and hydrochloride salts of bupropion in conscious rodents

David C Henshall, Nick Dürmüller, H Steve White, Robert Williams, et al.

Neuropsychiatric Disease and Treatment 2009, 5:189-206

Published Date: 12 March 2009

Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure

Domenico Servello, Marco Sassi, Stefano Bastianello, Guy Umberto Poloni, et al.

Neuropsychiatric Disease and Treatment 2009, 5:183-187

Published Date: 10 March 2009

Psychopharmacology of ADHD in pediatrics: current advances and issues

Donald E Greydanus, Ahsan Nazeer, Dilip R Patel

Neuropsychiatric Disease and Treatment 2009, 5:171-181

Published Date: 5 March 2009

Association of PDE11A global haplotype with major depression and antidepressant drug response

Huai-Rong Luo, Gui-Sheng Wu, Chuanhui Dong, Mauricio Arcos-Burgos, et al.

Neuropsychiatric Disease and Treatment 2009, 5:163-170

Published Date: 10 March 2009

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

Hisashi Higuchi, Kazuhiro Sato, Shingo Naito, Keizo Yoshida, Hitoshi Takahashi, et al

Neuropsychiatric Disease and Treatment 2009, 5:151-155

Published Date: 26 February 2009

Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD

Diane McIntosh, Stan Kutcher, Carin Binder, Anthony Levitt, Angelo Fallu, et al

Neuropsychiatric Disease and Treatment 2009, 5:137-150

Published Date: 5 March 2009

Desvenlafaxine in the treatment of major depressive disorder

Maria Teresa C Lourenco1, Sidney H Kennedy1,2

Neuropsychiatric Disease and Treatment 2009, 5:127-136

Published Date: 19 February 2009

Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors

Eman M Khedr, Sherifa A Hamed, Hala K El-Shereef, Ola A Shawky, Khalid A Mohamed, et al

Neuropsychiatric Disease and Treatment 2009, 5:103-116

Published Date: 15 February 2009

Combination therapy or monotherapy for the depressed type of schizoaffective disorder

Lubomira Izáková, Ivan Andre, Angelos Halaris

Neuropsychiatric Disease and Treatment 2009, 5:91-101

Published Date: 9 February 2009

Restless legs syndrome: differential diagnosis and management with rotigotine

Giovanni Merlino, Anna Serafini, Francesca Robiony, Mariarosaria Valente, Gian Luigi Gigli

Neuropsychiatric Disease and Treatment 2009, 5:67-80

Published Date: 21 January 2009

Excited delirium: Consideration of selected medical and psychiatric issues

Edith Samuel, Robert B Williams, Richard B Ferrell

Neuropsychiatric Disease and Treatment 2009, 5:61-66

Published Date: 21 January 2009

Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study

Gudlaug Tórsdóttir, Grétar Gudmundsson, Jakob Kristinsson, Jón Snaedal, Torkell Jóhannesson

Neuropsychiatric Disease and Treatment 2009, 5:55-59

Published Date: 6 March 2009

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone

Hong Liu-Seifert, Bruce J Kinon, Christopher J Tennant, Jennifer Sniadecki, Jan Volavka

Neuropsychiatric Disease and Treatment 2009, 5:47-54

Published Date: 22 January 2009

Emerging treatments for premature ejaculation: focus on dapoxetine

Wayne JG Hellstrom

Neuropsychiatric Disease and Treatment 2009, 5:37-46

Published Date: 21 December 2008

Update on ropinirole in the treatment of Parkinson’s disease

Holly A Shill, Mark Stacy

Neuropsychiatric Disease and Treatment 2009, 5:33-36

Published Date: 21 December 2008

Duloxetine for the treatment of generalized anxiety disorder: a review

Ahsan Y Khan, Matthew Macaluso

Neuropsychiatric Disease and Treatment 2009, 5:23-31

Published Date: 18 December 2008

Neonatal bilateral lidocaine administration into the ventral hippocampus caused postpubertal behavioral changes: An animal model of neurodevelopmental psychopathological disorders

Vanessa Blas-Valdivia, Edgar Cano-Europa, Adelaida Hernández-García, Rocio Ortiz-Butrón

Neuropsychiatric Disease and Treatment 2009, 5:15-22

Published Date: 2 December 2008

Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration

Julie Anne Seguin, Jordan Brennan, Emily Mangano, Shawn Hayley

Neuropsychiatric Disease and Treatment 2009, 5:5-14

Published Date: 2 December 2008

Aripiprazole in the treatment of Huntington’s disease: a case series

Andrea Ciammola, Jenny Sassone, Clarissa Colciago, Niccolò E Mencacci, Barbara Poletti, et al

Neuropsychiatric Disease and Treatment 2009, 5:1-4

Published Date: 25 November 2008